Metromile
-
“Tomorrow will be a better day.” “Next year will be a better year.” “The coming decade will be when this industry realizes its true potential.” We hear the same for most public enterprises.
-
The InsurTechs’ results show the path to profitability remains unclear, even as Lemonade said it expects to be self-funding from here.
-
The all-cash deal was completed following the closure of Metromile’s $500mn acquisition by Lemonade last week.
-
Last November, Lemonade struck a deal to buy the Californian InsurTech in an all-stock transaction, implying a diluted equity value of $500mn, or $200mn net of cash.
-
Metromile’s Preston and Lemonade co-CEOs Wininger and Schreiber all joined industry stalwarts in this year’s top 10.
-
The executive discussed InsurTech challenges, his priorities for Branch, fundraising, and his concerns about the capital markets.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
Embedded insurance can help sidestep some of the challenges faced by InsurTech 1.0.
-
Inside P&C’s news team runs you through the key developments from the past week.
-
Following the announcement of the delay, Metromile shares rose over 9% earlier this morning to just under $0.90 per stock.
-
Inside P&C’s morning summary of the key stories to get you up to speed fast.
-
The companies have received approval from the Department of Justice under the Hart-Scott-Rodino Act and are awaiting other required regulatory approvals.
-
Companies that had easily lured investors with major premium growth are now scrambling to prove their fundamentals work, and are sitting out fundraising to avoid a down round.
-
March’s CPI report shows elevated inflation levels, including vehicle CPI of 10.5% and average used car price increase of 24.7%.
-
Following the acquisitions of Trov and Insureon, what InsurTech M&A deals are next?
-
The auto InsurTech’s accident period loss ratio grew to 78.1% during the quarter, up from 56.9% at the same point last year.
-
The merger proposal was supported by at least 95.9% of the votes cast at during a special meeting of stockholders on Tuesday.
-
The next generation must stay private longer, employ a partnership approach to capital and take the complexities of insurance more seriously.
-
Stock prices fluctuated, and InsurTech short-sellers took some profits.
-
The InsurTech’s stock traded at $28.25 by midday Tuesday, down from its $163.93 peak in February 2021.
-
The latest report shows even higher inflation pushing up severity, forcing carriers to take rate.
-
InsurTechs, including Lemonade, Root, Hippo, and Metromile, shed some short interest but remain the target of choice for short-sellers.
-
Lemonade, Root, and Metromile remain the focus of short sellers, as most firms see little short interest change.
-
Inside P&C dissects the biggest deals of the year across broking, commercial lines and InsurTech.
-
Carriers are planning for inflationary threats and have been responding to major catastrophes, while the InsurTech and broking markets have driven M&A drama.
-
The monthly CPI report shows that inflation continues to push severity higher as carriers take rate in response.
-
Lemonade and Root remain the focal points of short sellers, while Metromile’s stock loan fee rate increases (pending acquisition).
-
Short interest fell in InsurTechs, but not enough to ease the pressure on the sector.
-
Metromile reported a contribution loss of $2.1mn in the third quarter compared with a contribution profit of $4.7mn in the prior-year period, as the loss ratio at the auto carrier continued to swell.
-
The deal derisks its early auto build-out, likely delays its next capital raise and still stands a good chance of delivering InsurTech alchemy.
-
Lemonade expects that Metromile will be a key to run faster through a competitive auto insurance market while assuming fewer risks on the road.
-
InsurTech shares trade mixed in response to Lemonade-Metromile combination.
-
Lemonade CEO Daniel Schreiber told analysts that the Metromile acquisition will put the InsurTech “at the vanguard of car insurance”.
-
Lemonade’s acquisition of Metromile helps both firms redirect focus from ongoing challenges.
-
Root and Lemonade remain the highest-shorted stocks covered, as short interest in most firms remains flat in anticipation of earnings.
-
The move is part of the InsurTech’s efforts to expand its independent agents program.
-
The private equity-backed retail brokers have lessons to teach the sector’s tech start-ups.
-
Without any major catalysts, the short interest for the industry was muted, with movement centering around InsurTechs once again.
-
Pressure on Root cools following stock price dips, but persistent short interest in InsurTechs suggests that prices haven’t bottomed out yet.
-
Ida soaks the tri-state – and has the potential to affect personal auto carriers more than comparable storms of the past.
-
The Inside P&C Select Index outperformed the S&P 500 (5.7% to 2.9%) in August, despite Hurricane Ida making landfall.
-
Pressure on the InsurTechs – specifically Root and Lemonade – is intensifying.
-
InsurTech short interest dwarfs legacy insurers as they come under pressure to produce profits.
-
Analysts downgrade Metromile stock after disappointing Q2 results, weakened forecast.
-
Claims inflation, elevated cancelation rates and consumer behavioral changes weighed on the InsurTech’s Q2 performance.
-
The InsurTech said it now expects to hit the 2021 target forecast of between $143mn to $176mn by the third quarter of 2022.
-
Financial executive Sandra Clarke is also joining the board, as famed Spac investor Betsy Cohen, who joined the group in February, steps down.
-
Changes in short interest were muted despite large stock moves, including big rises at HCI and Lemonade.